Bolton NHS Foundation Trust, Farnworth, Bolton, UK.
Faculty of Psychology, Health and Social Care, Manchester Metropolitan University, Manchester, UK.
J Clin Nurs. 2023 Mar;32(5-6):812-824. doi: 10.1111/jocn.16370. Epub 2022 May 19.
To assess the impact of educational interventions on the knowledge and attitude of healthcare professionals (HCPs) regarding sickle cell disease (SCD) pain management in the UK.
Variations and inadequate pain management due toHCPs' lack of knowledge and negative attitude is still an ongoing global concern for SCD patients despite availability of effective treatment and evidence-based guidelines. Several international studies have implemented interventions aimed at improving knowledge, attitude, and pain management. No review on the effectiveness of these interventions was found. Also, no previous intervention done in the UK was found from the thorough search of research databases. However, there are estimated 240,000 genetic carriers with about 12,500-15,000 estimated people living with SCD in the UK.
Rapid Evidence Assessment of existing evidence.
A rapid evidence assessment was conducted between March 2021-January 2022 following the PRISMA 2020 guidelines. Included papers must have an educational intervention about SCD or related symptom management where the learners were HCPs. Excluded papers were those not published in English or before 2010. The following databases were searched: CINAHL, MEDLINE, PubMed America and Europe, Scopus, PsycINFO and Web of Science. Data quality was assessed using the Mixed Methods Assessment Tool (MMAT) and analysed using a narrative approach.
Ten studies were included in the final review. Overall, they reported improved outcomes in six main themes: knowledge, attitude, perception, adoption, satisfaction and efficiency. Five studies reported statistically significant improvement in at least one outcome, four studies reported positive improvement, and two studies reported no significant improvement in knowledge and attitude. These heterogeneous studies were implemented once, and all designs were prone to bias; this makes it difficult to state how effective interventions are for SCD.
Current evidence of positive improvement in HCPs' knowledge and attitude is insufficient for generalisation and recommendation for adoption. However, we believe that implementing validated educational interventions remains essential for effective acute SCD pain management and patient-centred care. Further research is needed to find a suitable educational intervention that can be replicated.
Quality SCD education, timely crisis management and reduced patient stigma are crucial in reducing the risk of rapid clinical decompensation to avoid developing life-threatening complications. Understanding SCD can also support the building of therapeutic relationships between the patient and practitioner.
This review was not registered.
评估教育干预对英国医疗保健专业人员(HCP)在镰状细胞病(SCD)疼痛管理方面的知识和态度的影响。
尽管有有效的治疗方法和循证指南,但由于 HCP 缺乏知识和消极态度,导致疼痛管理存在差异和不足,这仍然是 SCD 患者的一个持续的全球性问题。一些国际研究已经实施了旨在改善知识、态度和疼痛管理的干预措施。没有发现这些干预措施有效性的综述。此外,从彻底搜索研究数据库中也没有发现英国以前进行的任何干预措施。然而,英国估计有 24 万基因携带者,估计有 12500-15000 人患有 SCD。
对现有证据进行快速证据评估。
根据 PRISMA 2020 指南,于 2021 年 3 月至 2022 年 1 月进行了快速证据评估。必须包括关于 SCD 或相关症状管理的教育干预,学习者为 HCP 的论文。排除未以英文发表或发表于 2010 年之前的论文。搜索了以下数据库:CINAHL、MEDLINE、美国和欧洲的 PubMed、Scopus、PsycINFO 和 Web of Science。使用混合方法评估工具(MMAT)评估数据质量,并使用叙述方法进行分析。
最终综述纳入了 10 项研究。总体而言,它们报告了在以下六个主要主题方面的改善结果:知识、态度、认知、采用、满意度和效率。五项研究报告了至少一项结果的统计学显著改善,四项研究报告了积极的改善,两项研究报告了知识和态度没有显著改善。这些异质性研究仅实施了一次,所有设计都容易存在偏倚;因此,很难说明干预措施对 SCD 的有效性如何。
目前关于 HCP 知识和态度改善的证据尚不足以推广和推荐采用。然而,我们认为实施经过验证的教育干预措施对于有效的急性 SCD 疼痛管理和以患者为中心的护理仍然至关重要。需要进一步研究以找到一种可以复制的合适的教育干预措施。
SCD 教育质量、及时的危机管理和减少患者耻辱感对于降低快速临床恶化的风险、避免危及生命的并发症至关重要。了解 SCD 还可以支持在患者和从业者之间建立治疗关系。
本综述未进行注册。